Remifentanil and Remimazolam to Limit Patient Movement

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-50
SponsorEgymedicalpedia

About this trial

Local anesthetics (LA) may be administered by injection (retrobulbar, peribulbar, subconjunctival, lid, or facial block) or by instillation (topical anesthesia), Considerable drawbacks of local anesthesia in these patients include the fact that a few patients can remain comfortable on an operating table for procedures that exceed two or three hours.

Sedation may be helpful with LA to decrease the experience of discomfort, movement and anxiety, which may in turn positively influence hemodynamic parameters, patient satisfaction, and overall improve surgical safety. Sedatives used in eye surgeries include benzodiazepines, opioids, alpha-adrenoceptor agonists, and propofol.

Eligibility criteria

Qualifiers

Age > 40 years.

Both sexes.

American Society of Anesthesiology (ASA) physical status I-III.

Undergoing long-eye surgeries under local anesthesia using peribulbar block with an expected surgical time of more than one hour.

Disqualifiers

Patients on aspirin or anticoagulants.

Allergy to any study medication.

Drug abuse.

Uncontrolled hypertension.

Trial design

Treatments tested in this trial

  • Remifentanil

Treatment groups

70 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Egymedicalpedia

Lead sponsor

Al-Azhar University

Collaborator